Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...

Search trends reveal India’s wellness market shifting from home remedies to prescription weight-loss drugs, clinical ...

There has been a 27% YoY increase in sales of weight-loss drugs, especially after the launch of Mounjaro and Novo Nordisk's ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Pharmacotherapy is an effective, evidence-based treatment for people living with obesity, as part of a long-term, ...

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...

New NHS guidance warns that people coming off weight-loss medications such as Wegovy ( semaglutide) and Mounjaro ( ...

Patients who have undergone weight-loss treatment need better support after their treatment ends to maintain a healthy weight ...

JOANNA Higgenbottom spent almost $800 (£600) each month on takeaways, before Mounjaro helped her shed 23st. The 60-year-old ...

A post hoc analysis of the SUMMIT trial, published in JACC, reveals that baseline body mass index (BMI) and fat distribution ...

Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.